Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind-Controlled rehab: can brain waves restore walking after stroke?

NCT ID NCT07537530

Symptom relief Sponsor: g.tec medical engineering GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device called recoveriX that uses a brain-computer interface, electrical stimulation, and virtual reality to help stroke survivors improve their walking. Thirty participants who had a stroke at least six months ago were split into two groups: one used the full brain-monitoring system, and the other used electrical stimulation and virtual reality without the brain cap. The goal was to see if the brain-computer interface leads to better walking speed and safety compared to standard therapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
recoveriX PRO system (brain-computer interface with functional electrical stimulation and virtual reality)
What this could lead to
If it works, this could point toward a more effective, technology-driven rehabilitation method for improving walking after a stroke.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply to all stroke survivors. The device is complex and may not be widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2025

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 6-months or more post stroke * With a restriction of the lower extremities preventing the persons from activities of daily life * Participants must be German speaking. * Demonstrate intact cognition to provide informed consent and follow instructions. * Be able to perform TUG and 10MWT (3 times). Exclusion Criteria: * Debilitating conditions or vision impairment that would impede full participation in the study. * Other neurological conditions affecting the motor system or the compliance to the therapy (for example Polyneuropathy or Musculoskeletal Diseases). * Uncontrolled epilepsy or seizures * Significant circulatory disturbances of the stimulated extremities * Inability to independently maintain the seated position (without assistance) for about 60 minutes. * Pregnant * Active or passive implanted medical devices such as pacemakers which do not allow the use of FES. * Implanted metallic fragments in the upper and lower extremities which can limit the use of FES. * Under the influence of anesthesia or similar medication. * With fractures or lesions in the extremity to be stimulated. * Inadequate control of a BCI system. * Sensory disorders which can significantly affect the patient's ability to feel pain and to react to unsuitable proprioceptive stimuli. * Botulinum toxin treatment of his/her paretic lower limb during this study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • g.tec medical engineering GmbH

    Schiedlberg, Upper Austria, 4521, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.